Genetic associations to germinal centre formation in primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1253-1258

  Reksten, Tove Ragna ^a,b   Johnsen, Svein Joar Auglænd ^c   Jonsson, Malin Viktoria ^a   Omdal, Roald ^c   Brun, Johan G ^a,d   Theander, Elke ^e   Eriksson, Per ^f   Wahren Herlenius, Marie ^g   Jonsson, Roland ^a,d   Nordmark, Gunnel ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; EOTAXIN; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN BCL 2;

ADULT; AICDA GENE; ARTICLE; BANK1 GENE; BCL2 GENE; CARD8 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMINAL CENTER; HAPLOTYPE; HUMAN; HUMAN TISSUE; ICA1 GENE; IKBKE GENE; IL17A GENE; MAJOR CLINICAL STUDY; MALE; NORWAY; PKN1 GENE; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SWEDEN; TANK GENE;

CHEMOKINES; GENE POLYMORPHISM; INFLAMMATION; SJÉGREN'S SYNDROME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AUTOANTIGENS; BIOPSY; CARD SIGNALING ADAPTOR PROTEINS; CHEMOKINE CCL11; CYTIDINE DEAMINASE; FEMALE; GENE FREQUENCY; GENES, BCL-2; GERMINAL CENTER; HAPLOTYPES; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-17; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASE C; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 84899981675     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202500     Document Type: Article

References (53)

1. Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011;141: 1-9.
2. Båve U, Nordmark G, Lövgren T, et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52: 1185-95. (Pubitemid 40530126)
3. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48: 3187-201. (Pubitemid 37409331)
4. Halse A-K, Marthinussen MC, Wahren-Herlenius M, et al. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome. Scand J Rheumatol 2000;29: 13-9. (Pubitemid 30096945)
5. Jonsson MV, Skarstein K, Jonsson R, et al. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007;34: 2044-9. (Pubitemid 47548208)
6. Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011;70: 1363-8.
7. Szodoray P, Alex P, Jonsson MV, et al. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 2005;117: 168-76. (Pubitemid 41407727)
8. Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 2009;48: 1102-6.
9. Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, et al. HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2011;11: 281-7.
10. Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun 2009;10: 285-96.
11. Hjelmervik T, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52: 1534-44. (Pubitemid 40663945)
12. Nordmark G, Kristjansdottir G, Theander E, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 2008;10: 68-76.
13. Niewold TB, Kelly JA, Kariuki SN, et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis 2012;71: 463-9.
14. Cherian TS, Kariuki SN, Franek BS, et al. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus. Arthritis Rheum 2012;64: 3383-7.
15. Bolstad AI, Le Hellard S, Kristjansdottir G, et al. Association between genetic variants in the tumour necrosis factor/lymphotoxin alpha/lymphotoxin beta locus and primary Sjögren's syndrome in Scandinavian samples. Ann Rheum Dis 2012;71: 981-8.
16. Nordmark G, Kristjansdottir G, Theander E, et al. Association of EBF1, FAM167A (C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 2011;12: 100-9.
17. Ice JA, Li H, Adrianto I, et al. Genetics of Sjögren's syndrome in the genome-wide association era. J Autoimmun 2012;39: 57-63.
18. Lessard CJ, Ice JA, Adrianto I, et al. A high-density genome-wide association study by the Sjögren's Genetics Network identifies five novel susceptibility loci for primary Sjögren's syndrome and confirms association with MHC, IRF5, and BLK. Arthritis Rheum 2011;63(10 Suppl):S184.
19. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61: 554-8. (Pubitemid 34539104)
20. Fan JB, Oliphant A, Shen R, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 2003;68: 69-78. (Pubitemid 38955554)
21. Purcell S. PLINK. 1.07 ed. http://pngu.mgh.harvard.edu/purcell/plink/
22. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007;81.
23. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7: 781-91. (Pubitemid 44413222)
24. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19: 149-50. (Pubitemid 36150192)
25. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21: 263-5. (Pubitemid 40202029)
26. Lampinen M, Ronnblom A, Amin K, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 2005;54: 1714-20. (Pubitemid 41697669)
27. Wagner M, Peterson CG, Stolt I, et al. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study. Scand J Gastroenterol 2011;46: 849-54.
28. Neuwirth A, Dobes J, Oujezdska J, et al. Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase. Cell Immunol 2012;273: 158-63.
29. Nandula S-R, Scindia YM, Dey P, et al. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis 2011;17: 801-7.
30. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6: 1133-41. (Pubitemid 41541791)
31. Adarichev VA, Vermes C, Hanyecz A, et al. Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis. Autoimmunity 2006;39: 663-73. (Pubitemid 44964369)
32. Pietropaolo M, Castano L, Babu S, et al. Islet Cell Autoantigen 69 kD (ICA69): molecular cloning and characterisation of a novel diabetes-associated autoantigen. J Clin Invest 1993;92: 359-71. (Pubitemid 23209017)
33. Winer S, Astsaturov I, Cheung R, et al. Primary Sjögren's syndrome and deficiency of ICA69. Lancet 2002;360: 1063-9.
34. Budarf ML, Goyette P, Boucher G, et al. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 2011;12: 51-8.
35. Kozyrev SV, Abelson A-K, Wojcik J, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008;40: 211-16. (Pubitemid 351171404)
36. Aiba Y, Yamazaki T, Okada T, et al. BANK negatively regulates akt activation and subsequent B cell responses. Immunity 2006;24: 259-68.
37. Castillejo-Lopez C, Delgado-Vega AM, Wojcik J, et al. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann Rheum Dis 2011;71: 136-42.
38. Le Pottier L, Devauchelle V, Fautrel A, et al. Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009;182: 3540-7.
39. Tomer Y, Concepcion E, Greenberg D. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002;12: 1129-35. (Pubitemid 36114821)
40. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007;357: 1199-209. (Pubitemid 47443179)
41. Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008;40: 1062-4.
42. Gregersen PK, Amos CI, Lee AT, et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009;41: 820-3.
43. Fontalba A, Martinez-Taboada V, Gutierrez O, et al. Deficiency of the NF-κB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. J Immunol 2007;179: 4867-73.
44. Cheng G, Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-κB activation. Genes Dev 1996;10: 963-73.
45. Pomerantz JL, Baltimore D. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 1999;18: 6694-704.
46. Maecker H, Varfolomeev E, Kischkel F, et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell 2005;123: 931-44. (Pubitemid 41721037)
47. Jonsson M, Szodoray P, Jellestad S, et al. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005;25: 189-201. (Pubitemid 40884044)
48. Vora KA, Wang LC, Rao SP, et al. Cutting edge: germinal centers formed in the absence of B cell-cctivating factor belonging to the TNF family exhibit impaired maturation and function. J Immunol 2003;171: 547-51. (Pubitemid 36871360)
49. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2011;117: 1595-604.
50. Kuper-Hommel MJ, van Krieken JH. Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type. Leuk Lymphoma 2012;53: 1032-45.
51. Szyszko E, Brokstad K, Øijordsbakken G, et al. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011;13:R2.
52. Vinuesa CG, Sanz I, Cook MC. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009;9: 845-57.
53. Nutt SL, Tarlinton DM. Germinal center B and follicular helper T cells: siblings, cousins or just good friends? Nat Immunol 2011;12: 472-7.